![Michael Koby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Koby
Fondateur chez
1315 Capital LLC
Profil
Mr. Michael Koby is a Founding Partner at 1315 Capital LLC.
He is on the Board of Directors at CHC Medical Partners, Inc., JDS Therapeutics LLC and Solsys Medical LLC.
Mr. Koby was previously employed as an Independent Director by Misonix, Inc., a Managing Director by Palm Ventures LLC, a Principal by Galen Collaborative Capital, a Principal by Medtronic, Inc., a Principal by Novoste Corp., and an Investment Banker by Dillon, Read & Co., Inc. He also served on the board at Soteira, Inc.
He received his undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Michael Koby
| Sociétés | Poste | Début |
|---|---|---|
JDS Therapeutics LLC
 JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a portfolio of proprietary, clinically supported nutraceutical products focused around diabetes and related indications | Directeur/Membre du Conseil | - |
1315 Capital LLC
 1315 Capital LLC Investment ManagersFinance 1315 Capital invests in private companies located in the United States with revenues of USD 50 - 200 million. The firm focuses on companies operating in the fields of healthcare services, medical technology, medtech & pharma outsourcing and health & wellness companies. It provides financing for growth and buyout stage capital requirements with an investment size ranging from USD 15 to 50 million. | Fondateur | 01/05/2014 |
Solsys Medical LLC
 Solsys Medical LLC BiotechnologyHealth Technology Manufactures and distributes wound care products | Directeur/Membre du Conseil | - |
CHC Medical Partners, Inc.
 CHC Medical Partners, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Koby
| Sociétés | Poste | Fin |
|---|---|---|
| MISONIX, INC. | Directeur/Membre du Conseil | 29/10/2021 |
Palm Ventures LLC
 Palm Ventures LLC Investment ManagersFinance Palm Ventures invests in both private and public small companies located in the United States. The firm focuses across a broad range of sectors and industries. It participates in early, later stage and buyout transactions in the form of equity and debt. The firm acquires majority interests. | Private Equity Investor | 01/05/2014 |
Galen Management LLC
 Galen Management LLC Investment ManagersFinance Galen Management invests in companies located in the United States with revenues of USD 10 - 100 million and EBITDA of USD 0 - 9 million. The firm focuses on the health sector. It participates in growth capital requirements with an investment size of USD 10 - 100 million and also acquires minority or majority stakes. | Analyste en capital-investissement | 16/06/2010 |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Corporate Officer/Principal | 01/08/2003 |
Novoste Corp.
 Novoste Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Corporate Officer/Principal | 31/12/2002 |
Formation de Michael Koby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Misonix, Inc.
 Misonix, Inc. Medical SpecialtiesHealth Technology Manufactures therapeutic ultrasonic medical devices | Health Technology |
Novoste Corp.
Novoste Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Solsys Medical LLC
Solsys Medical LLC BiotechnologyHealth Technology Manufactures and distributes wound care products | Health Technology |
Dillon, Read & Co., Inc.
 Dillon, Read & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galen Management LLC
Galen Management LLC Investment ManagersFinance Galen Management invests in companies located in the United States with revenues of USD 10 - 100 million and EBITDA of USD 0 - 9 million. The firm focuses on the health sector. It participates in growth capital requirements with an investment size of USD 10 - 100 million and also acquires minority or majority stakes. | Finance |
Soteira, Inc.
 Soteira, Inc. Medical SpecialtiesHealth Technology Develops surgical devices | Health Technology |
CHC Medical Partners, Inc.
CHC Medical Partners, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Palm Ventures LLC
Palm Ventures LLC Investment ManagersFinance Palm Ventures invests in both private and public small companies located in the United States. The firm focuses across a broad range of sectors and industries. It participates in early, later stage and buyout transactions in the form of equity and debt. The firm acquires majority interests. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a portfolio of proprietary, clinically supported nutraceutical products focused around diabetes and related indications | Health Technology |
1315 Capital LLC
1315 Capital LLC Investment ManagersFinance 1315 Capital invests in private companies located in the United States with revenues of USD 50 - 200 million. The firm focuses on companies operating in the fields of healthcare services, medical technology, medtech & pharma outsourcing and health & wellness companies. It provides financing for growth and buyout stage capital requirements with an investment size ranging from USD 15 to 50 million. | Finance |
